Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00693940 · ClinicalTrials.gov registry record · Phase 3

Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])

A Phase 3 study, sponsored by Northwestern University.

Completed
Registry status
Phase 3
Development phase
194
Enrollment target

NCT00693940 is a Phase 3 study that has completed, run by Northwestern University. The registered enrollment target is 194 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00693940, a Phase 3 study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
Phase 3
Development phase
194 participants
Enrollment target

Study Summary

Lower extremity peripheral arterial disease (PAD) is a disease in which fatty build-up, or plaque, accumulates in the arteries of the legs. People with lower extremity PAD often experience leg pain while walking, which is caused by reduced blood flow to the legs. Regular walking has significant benefits for people with blood flow problems in their legs, but previous studies have shown that most men and women with PAD do not walk for exercise on a regular basis. A group home-based walking program may help people with PAD to walk more often and improve their lower extremity functioning. This study will evaluate the effectiveness of a home-based group mediated cognitive behavioral (GMCB) exercise program in helping people with lower extremity PAD to increase their walking frequency and improve their lower leg functioning.

Interventions

  • BEHAVIORAL Group mediated cognitive behavioral (GMCB) sessions
  • OTHER Health education sessions

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2008-06
Est. Completion 2013-05
Phase Phase 3

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT00693940

The ClinicalTrials.gov registry entry for NCT00693940 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Group mediated cognitive behavioral (GMCB) sessions is the first listed.

NCT00693940 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00693940 about?

NCT00693940 is a clinical study titled "Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])". Lower extremity peripheral arterial disease (PAD) is a disease in which fatty build-up, or plaque, accumulates in the arteries of the legs. People with lower extremity PAD often experience leg pain while walking, which is caused by reduced blood flow to the legs. Regular walking has significant bene...

What is the current status of trial NCT00693940?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 194 participants. The study started on 2008-06. Estimated completion is 2013-05.

What interventions are being tested in trial NCT00693940?

The interventions under investigation include: Group mediated cognitive behavioral (GMCB) sessions (BEHAVIORAL), Health education sessions (OTHER).

Who is sponsoring clinical trial NCT00693940?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.